AbbVie
In Joel Greenblatt's portfolio · Gotham Asset Management
Ticker ABBV
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Gotham Asset Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2021 | Add 82% | 105,294 | 0.5% |
| Q2 2020 | Add 51% | 199,665 | 0.6% |
| Q2 2019 | Add 11% | 408,509 | 0.5% |
| Q2 2018 | Reduce 12% | 389,799 | 0.5% |
| Q1 2018 | Add 86% | 444,814 | 0.6% |
| Q3 2017 | Add 34% | 398,837 | 0.5% |
| Q1 2017 | Reduce 34% | 618,480 | 0.5% |
| Q4 2016 | Add 37% | 935,437 | 0.8% |
| Q3 2016 | Reduce 24% | 684,356 | 0.6% |
| Q2 2016 | Add 40% | 905,598 | 0.7% |
| Q1 2016 | Add 216% | 645,835 | 0.4% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.